MURANO study: exciting times in CLL

Data from the Phase III MURANO study (NCT02005471) in relapsed/refractory chronic lymphocytic leukemia (CLL) was highly anticipated at the American Society of Hematology (ASH) 2017 Annual Meeting and ... Author: VJHemOnc Added: 02/09/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts